Skip to main content

Oncology News

News
Although previous findings have been mixed, a large study suggests omega-3 fatty acid and vitamin D supplementation may confer some preventive benefits when it comes to cardiovascular disease (CVD) and cancer, according to new research presented at the 2019 North American Menopause Society Annual…
News
By Will Boggs MD NEW YORK (Reuters Health) - Oral antibiotic use appears to increase the risk of colon cancer and reduce the risk of rectal cancer, according to a database study. "Our findings highlight that careful and appropriate use of antibiotics is very important, not only for avoidance of…
News
Researchers recently compared how the use of lipophilic or hydrophilic statins impacted hepatocellular carcinoma (HCC) in patients with viral hepatitis. According to the research team, prior to the study, it was unknown whether statin type influenced HCC incidence or mortality in patients with…
News
A Class I recall has been issued for more than 14,000 vials of Fresenius Kabi and Novaplus brand fluorouracil injection because of the potential presence of glass particulate, according to the July 24, 2019, US Food and Drug Administration (FDA) Enforcement Report.  “Products containing glass…
News
By Megan Brooks NEW YORK (Reuters Health) - Vitamin-D supplementation could have a role in treating some types of cancer, but the findings are not clear-cut, according to two randomized controlled trials online in JAMA today. The phase 2 SUNSHINE trial found that supplementing standard…
News
By Reuters Staff NEW YORK (Reuters Health) - Many preventive drugs could be safely discontinued, with substantial cost savings, in the last year of life of older adults with cancer, according to a retrospective study of Swedish data. Earlier observational studies have cast doubt on the benefit of…
News
By David Douglas NEW YORK (Reuters Health) - A substantial minority of patients with advanced gastrointestinal stromal tumors (GIST) treated with imatinib mesylate show long-term survival, according to a trial analysis presenting new molecular data. As Dr. Michael Heinrich explained in an email…
News
The US Food and Drug Administration granted accelerated approval for Opdivo® (nivolumab; Bristol-Myers) to be used as bladder cancer treatment for patients who have locally advanced unresectable or metastatic urothelial carcinoma following progression on a platinum-containing therapy. The decision…
News
In a study published in Cancer, a team of French researchers suggest that pioglitazone in combination with imatinib may safely improve outcomes for patients with chronic myeloid leukemia (CML). ------ Related Content Does Pioglitazone Increase Bladder Cancer Risk? Reducing Diabetes Progression…
News
Researchers may have developed a new treatment regimen that prevents chemotherapy-induced hearing loss in children with cancer. ----- Related Content Rotating pazopanib and everolimus no extra help in renal cancer Widely used oncology tests show disparate results ----- In preclinical studies…
Back to Top